| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2 | 6 | 6 | 94 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 2 | 6 | 6 | 94 | | | Operating Expenses | | Research Development | 4,433 | 1,859 | 1,913 | 2,402 | | Selling General and Administrative | 3,385 | 1,574 | 1,466 | 1,391 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,817) | (3,427) | (3,373) | (3,699) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,015 | (11,204) | (1,242) | (596) | | Earnings Before Interest And Taxes | (2,776) | (14,631) | (4,615) | (4,295) | | Interest Expense |
-
|
-
|
-
| (13) | | Income Before Tax | (2,776) | (14,631) | (4,615) | (4,282) | | Income Tax Expense |
-
|
-
|
-
| 3,760 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,599) | (14,631) | (4,615) | (8,042) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,599) | (14,631) | (4,615) | (8,042) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,599) | ($14,631) | ($4,615) | ($8,042) |
|
0.03% Nasdaq 0.00%
Income Statement
